Christopher Smith, MD | |
7900 Fm 1826 Bldg 2, Austin, TX 78737-1407 | |
(512) 416-0044 | |
Not Available |
Full Name | Christopher Smith |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 7900 Fm 1826 Bldg 2, Austin, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023024387 | NPI | - | NPPES |
080141925 | Medicaid | TX | |
044987801 | Medicaid | TX |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | K0201 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Christopher Smith, MD 2512 S Interstate 35, Ste 310, Austin, TX 78704-5758 Ph: (512) 900-5844 | Christopher Smith, MD 7900 Fm 1826 Bldg 2, Austin, TX 78737-1407 Ph: (512) 416-0044 |
News Archive
Ingenix, a leading provider of health information, technology and consulting services, and A-Life Hospital, a wholly owned subsidiary of A-Life Medical, today announced an agreement to connect the Ingenix Web.Strat™ encoder with Actus®, A-Life Hospital's computer-assisted coding (CAC) application.
Celator Pharmaceuticals today announced that new data from a preclinical leukemia study in mice demonstrate that its lead product, CPX-351 (Cytarabine:Daunorubicin) Liposome Injection, alone or in combination with clofarabine or azacytidine can improve treatment outcomes compared to the combination of either agent with the conventional (unencapsulated) cytarabine:daunorubicin regimen.
UT Southwestern researchers have succeeded in neutralizing what they believe is a primary factor in late-onset Alzheimer's disease, opening the door to development of a drug that could be administered before age 40, and taken for life, to potentially prevent the disease in 50 to 80 percent of at-risk adults.
Encorium Group, Inc., a full-service multinational contract research organization (CRO) that provides design, development, and management capabilities for clinical trials and patient registries to many of the world's leading pharmaceutical companies, today announced that it has completed a private placement of 3,937,500 shares of its common stock with a private investor for an aggregate purchase price of $1,575,000, or $.40 per share.
Scientists from the University of Colorado Cancer Center have once again advanced the treatment of a specific kind of lung cancer. The team has documented how anaplastic lymphoma kinase (ALK) positive advanced non-small cell lung cancer (NSCLC) becomes resistant to a drug targeting the abnormal protein in the cancer. It's the first time scientists have analyzed the frequency and type of drug resistance in ALK positive patients taking crizotinib.
› Verified 1 days ago
Robert Obrien, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4316 James Casey St, Bldg F200, Austin, TX 78745 Phone: 512-791-7555 | |
Jason B Holinbeck, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1301 W 38th St Ste 102, Austin, TX 78705 Phone: 512-454-4561 Fax: 512-406-7330 | |
David L. Purtle, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1921 Lohmans Crossing Rd Ste 150, Austin, TX 78734 Phone: 737-717-8430 Fax: 737-717-8469 | |
Dr. Jared Kealy, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 6937 N Interstate 35 Ste 2, Austin, TX 78752 Phone: 877-800-5722 | |
Dr. Barbara Lynne Gray, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12505 Hymeadow Dr, Suite 2a, Austin, TX 78750 Phone: 512-219-8991 Fax: 512-219-8996 | |
Dr. Albert Edward Meisenbach Iii, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 100 West Dean Keeton, Austin, TX 78712 Phone: 512-475-8335 Fax: 512-471-0898 | |
Dr. Kanakadurga Govindaraju, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 4107 Spicewood Springs Rd Ste 100, Austin, TX 78759 Phone: 512-397-3360 Fax: 512-343-7107 |